CYP1A1 Genetic Variants and Liver Cancer Risk in Smokers
Author Information
Author(s): Yu M-W, Chiu Y-H, Yang S-Y, Santella R M, Chern H-D, Liaw Y-F, Chen C-J
Primary Institution: National Taiwan University
Hypothesis
Are CYP1A1 polymorphisms related to the risk of hepatocellular carcinoma among chronic hepatitis B carriers?
Conclusion
CYP1A1 polymorphisms may increase the risk of liver cancer in smokers who are chronic hepatitis B carriers.
Supporting Evidence
- CYP1A1 polymorphisms may modulate the risk of hepatocellular carcinoma in smokers.
- The MspI variant allele increases HCC risk among smokers.
- No overall association between CYP1A1 genotypes and HCC was observed.
Takeaway
This study found that certain genetic variations can make smokers more likely to get liver cancer if they also have chronic hepatitis B.
Methodology
Genotypic variants of CYP1A1 were determined using polymerase chain reaction in cases of HCC and controls from a cohort study.
Limitations
The study did not find an overall association between CYP1A1 genotypes and HCC risk.
Participant Demographics
81 incident cases of HCC and 409 controls, all male chronic HBV carriers.
Statistical Information
P-Value
0.0196
Statistical Significance
p=0.0196
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website